Launched to coincide with the 2004 International AIDS Conference in Bangkok, in this strategy document, the IAVI outlines plans to strengthen and expand the research and development pipeline of candidate HIV vaccines, and engage as partners those countries most affected by HIV/AIDS. Future scientific strategy includes focusing on vaccines that trigger neutralising antibodies, and understanding how live weakened vaccines work in animal models for clues to what is needed in a vaccine for protecting people.